Get started
Author

Thijs T. Wind

Observed names: T. T. Wind, T.T. Wind, Thijs Wind, Wind, T. T.
ORCID: 0000-0002-3879-3080
Observed ORCID: 0000-0002-3879-3080
OpenAlex ID: A5064056540
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
2024 · Johannes R. Björk, Laura A. Bolte, et al. · Nature Medicine · 154
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
2020 · Thijs T. Wind, Ranko Gacesa, et al. · Melanoma Research · 73
PDF
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
2020 · Pieter A. Boonstra, Thijs T. Wind, et al. · Cancer and Metastasis Reviews · 60
PDF
89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
2019 · Kirsten L. Moek, Stijn J.H. Waaijer, et al. · Clinical Cancer Research · 54
PDF
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
2021 · Pim P. van de Donk, Thijs T. Wind, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 48
PDF
Checks and Balances in Autoimmune Vasculitis
2018 · Rebeca Hid Cadena, Wayel H. Abdulahad, et al. · Frontiers in Immunology · 39
PDF
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program
2019 · Cornelis Bisschop, Thijs T. Wind, et al. · Journal of Immunotherapy · 22
Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma
2021 · Annemarie C. Eggen, Thijs T. Wind, et al. · Cancer Medicine · 14
PDF
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
2023 · Olivier J. van Not, Thijs T. Wind, et al. · Cancers · 4
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
2019 · Thijs T. Wind, Mathilde Jalving, et al. · OncoImmunology · 3
PDF
Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas
2018 · K.L. Moek, S.J.H. Waaijer, et al. · Annals of Oncology · 1
Biomarkers for response to immune checkpoint inhibitors in metastatic melanoma
2024 · Thijs Wind
PDF
Supplementary Data_clean from 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
2023 · Kirsten L. Moek, Stijn J.H. Waaijer, et al.
Supplementary Data_clean from 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
2023 · Kirsten L. Moek, Stijn J.H. Waaijer, et al.
Data from 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
2023 · Kirsten L. Moek, Stijn J.H. Waaijer, et al.
Data from 89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
2023 · Kirsten L. Moek, Stijn J.H. Waaijer, et al.
Functional genomic analysis of melanoma to identify markers for clinical response to adjuvant immunotherapy in a population based registry
2015 · Thijs T. Wind
Works count: 18
Citation count: 471
H-index: 8
I10-index: 8
Year
Topic
Type